Successful management of cutaneous lymphangitis carcinomatosa arising from cervical cancer with paclitaxel-cisplatin and bevacizumab combination therapy: a case report and review of the literature
ConclusionOur findings suggest that combination chemotherapy plus bevacizumab is an effective therapeutic option in patients with cutaneous lymphangitis carcinomatosa arising from cervical cancer.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Avastin | Bleeding | Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Chemotherapy | CT Scan | General Medicine | Japan Health | PET Scan | Skin | Skin Biopsy | Squamous Cell Carcinoma | Women